Literature DB >> 17695258

Fluorescence resonance energy transfer-based method for detection of DNA binding activities of nuclear factor kappaB.

Hua-Jun He1, Rick Pires, Tie-Nian Zhu, Anhong Zhou, Adolfas K Gaigalas, Sige Zou, Lili Wang.   

Abstract

The DNA binding protein nuclear factor kappaB (NF-kappaB) and the cellular signaling pathways in which it participates are the central coordinators of many biological processes, including innate and adaptive immune responses, oxidative stress response, and aging. NF-kappaB also plays a key role in diseases, for example, cancer A simple, convenient, and high-throughput detection of NF-kappaB activation is therefore important for systematically studying signaling pathways and for screening therapeutic drug targets. We describe a method based on fluorescence resonance energy transfer (FRET) to directly measure the amount of activated NF-kappaB. More specifically, a double-stranded DNA (dsDNA) probe was designed to contain a pair of FRET fluorophores at the same end of the probe and an endonuclease binding site within the NF-kappaB consensus sequence. The activated NF-kappaB was detected by FRET following the restriction enzyme digestion. Using three different analyte materials--(i) purified recombinant NF- kappaB p50, (ii) nuclear extracts, and (iii) whole cell lysates--we demonstrated that this assay is as sensitive as the traditional, widely used electrophoretic mobility shift assay (EMSA), but much less labor-intensive for measuring NF-kappaB DNA binding activities. In addition, this FRET-based assay can be easily adapted for high-throughput screening of NF-kappaB activation.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17695258     DOI: 10.2144/000112475

Source DB:  PubMed          Journal:  Biotechniques        ISSN: 0736-6205            Impact factor:   1.993


  1 in total

1.  A rapid and high-throughput quantitation assay of the nuclear factor κB activity using fluorescence correlation spectroscopy in the setting of clinical laboratories.

Authors:  Kenu Harada; Shintaro Mikuni; Hideyuki Beppu; Hideki Niimi; Shigeki Abe; Nobuko Hano; Koichi Yamagata; Masataka Kinjo; Isao Kitajima
Journal:  PLoS One       Date:  2013-10-04       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.